Evidence map›Paper›PMID 37292143›Full record

ArticleFrontiers in genetics2023

Corrigendum: Prognostic implication and immunotherapy response prediction of a ubiquitination-related gene signature in breast cancer.

Yangyang Guo, Qiaoqiao Chen, Yingjue Zhang, Xu Cheng, Kenan Cen, Ying Dai, Yifeng Mai, Kai Hong

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 76% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Yangyang GuoDepartment of Thyroid and Breast Surgery, Ningbo First Hospital, Ningbo, China.
Qiaoqiao ChenReproductive Medicine Center, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
Yingjue ZhangDepartment of Molecular Pathology, Division of Health Sciences, Graduate School of Medicine, Osaka University, Suita, Japan.
Xu ChengTaizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, China.
Kenan CenThe Affiliated Hospital of Medical School of Ningbo University, Ningbo, China.
Ying DaiThe Affiliated Hospital of Medical School of Ningbo University, Ningbo, China.
Yifeng MaiThe Affiliated Hospital of Medical School of Ningbo University, Ningbo, China.
Kai HongDepartment of Thyroid and Breast Surgery, Ningbo First Hospital, Ningbo, China.
Ningbo University Affiliated Hospital · CNNingbo No. 2 Hospital · CNSir Run Run Shaw Hospital · CNThe University of Osaka · JPWenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fgene.2022.1038207.].

Indexed as

breast cancerimmunotherapyLASSOsignaturetumor microenvironmentubiquitination

Identifiers

PMID37292143
PMCPMC10245520
OpenAlexW4378083313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.